RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.31), $0.22 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.28 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.